Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-18-108717
Filing Date
2018-04-05
Accepted
2018-04-05 16:07:34
Documents
128
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A d516439d20fa.htm 20-F/A 24079
  Complete submission text file 0001193125-18-108717.txt   7733112

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT ablx-20171231.xml EX-101.INS 2257356
3 XBRL TAXONOMY EXTENSION SCHEMA ablx-20171231.xsd EX-101.SCH 118958
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ablx-20171231_cal.xml EX-101.CAL 110034
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ablx-20171231_def.xml EX-101.DEF 325093
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ablx-20171231_lab.xml EX-101.LAB 639941
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ablx-20171231_pre.xml EX-101.PRE 516173
Mailing Address TECHNOLOGIEPARK 21 ZWIJNAARDE GHENT C9 9052
Business Address TECHNOLOGIEPARK 21 ZWIJNAARDE GHENT C9 9052 003292620000
Ablynx NV (Filer) CIK: 0001617582 (see all company filings)

EIN.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-38259 | Film No.: 18740664
SIC: 2836 Biological Products, (No Diagnostic Substances)